Проф. д.м.н. Mahmut Emre Yıldırım

ОБРАЗОВАНИЕ И СПЕЦИАЛИЗАЦИЯ

• 1995 – 2002
  Медицинский факультет Джеррахпаша Стамбульского университета
• 2002 – 2008
  Медицинский факультет Джеррахпаша Стамбульского университета — ординатура по внутренним болезням
• 2008 – 2009
  Учебно-исследовательская больница Fatih Sultan Mehmet — внутренние болезни
• 2009 – 2012
  Учебно-исследовательская больница Kartal Dr. Lütfi Kırdar — ординатура по медицинской онкологии
• 2013 – 2015
  Учебно-исследовательская больница Ankara Dr. Zekai Tahir Burak — медицинская онкология
• 2015
  Учебно-исследовательская больница Kartal Dr. Lütfi Kırdar — Главный ассистент, медицинская онкология
• 2017 – по настоящее время
  Присвоено звание Доцент по медицинской онкологии

ПРОФЕССИОНАЛЬНЫЙ ОПЫТ

• 2017 – 2023
  Городская больница Kartal Dr. Lütfi Kırdar —
  Клиника медицинской онкологии — Руководитель образовательной и административной деятельности
• Университет медицинских наук — Преподаватель

ПРОФЕССИОНАЛЬНЫЕ ЧЛЕНСТВА

• Турецкое общество медицинской онкологии — Член правления
• Онкологическая ассоциация Мармары — Член правления
• ASCO — American Society of Clinical Oncology
• ESMO — European Society for Medical Oncology
• ABCIP
• Стамбульская медицинская палата

A. Статьи, опубликованные в международных рецензируемых журналах

• A1. Yıldırım, M.E., Kefeli, U., Aydın, D., Şener, N., Gümüş, M. (2016). The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker. Tumor Biology. DOI: 10.1007/s13277-016-5025-
• A2. Kefeli, U., Yıldırım, M.E., Aydın, D., Çakır Madenci, Ö., Yaşar, N., Şener, N., Güven, M.A., Yüksel, S., Balvan, Ö., Korkmaz, T., Gümüş, M. (2012). Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers, 17(7), 663–667. DOI: 10.3109/1354750X.2012.709882
• A3. Oyman, A., Başak, M., Özçelik, M., Özyükseler, D.T., Işık, S., Yıldırım, M.E. (2020). Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis. Asia Pac J Clin Oncol, Sep. DOI: 10.1111/ajco.13426
• A4. Aydın, D., Sendur, M.A., Kefeli, U., Ustaalioglu, B.B., Aydın, O., Yıldırım, E., Isık, D., Surmeli, H., Oyman, A., Isik, S., Şener, N., Ercelep, O., Odabaş, H., Aliustaoğlu, M., Gümüş, M. (2017). Evaluation of Bevacizumab in advanced small bowel adenocarcinoma. Clin Colorectal Cancer, 16, 78–83. DOI: 10.1016/j.clcc.2016.04.013
• A5. Bilici, A., Seker, M., Ustaalioglu, B.B., Kefeli, U., Yıldırım, E., Yavuzer, D., Aydın, F.M., Salepci, T., Oncel, M., Gümüş, M. (2010). Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection. Ann Surg Oncol, 17, 2037–2044. DOI: 10.1245/s10434-010-1027-y
• A6. Bilici, A., Ustaalioglu, B.B., Gümüş, M., Seker, M., Yılmaz, B., Kefeli, U., Yıldırım, E., Sonmez, B., Salepci, T., Kement, M., Mayadagli, A. (2010). Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie, 33, 101–105. DOI: 10.1159/000277927
• A7. Seker, M., Bilici, A., Guler, D.O., Ustaalioglu, B.B., Gozu, H., Erkal, F.Y., Sonmez, B., Karaduman, M., Kefeli, U., Yıldırım, E., Salepci, T., Gümüş, M. (2011). Tissue and serum adiponectin levels in patients with gastric cancer: Are there any correlations between adiponectin levels and histopathological variables? Hepatogastroenterology, 58, 110–111. DOI: 10.5754/hge10288
• A8. Ustaalioglu, B.B.O., Bilici, A., Kefeli, U., Seker, M., Yıldırım, E., Salepci, T., Oncel, M., Kement, M., Gümüş, M. (2010). Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: Single-center experiences. Oncology, 79, 105–111. DOI: 10.1159/000320162
• A9. Kefeli, U., Bilici, A., Ustaalioglu, B.O., Kefeli, A.U., Yıldırım, M.E., Seker, M., Gümüş, M. (2011). A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy. Arch Gynecol Obstet, 283, 405–407. DOI: 10.1007/s00404-010-1519-9
• A10. Kefeli, U., Kaya, S., Ustaalioglu, B.O., Bilici, A., Kefeli, A.U., Yıldırım, M.E., Seker, M., Yılmaz, B., Salepci, T., Uygun, K., Gümüş, M. (2011). Prognostic factors in elderly patients with non-small cell lung cancer: A two-center experience. Med Oncol, 28, 661–666. DOI: 10.1007/s12032-010-9504-5
• A11. Seker, M., Ustaalioglu, B.B., Bilici, A., Yıldırım, M.E., Kefeli, U., Barişik, N.O., Tamer, I., Gümüş, M. (2010). Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma. Leuk Res, 34, e160–163. DOI: 10.1016/j.leukres.2010.02.013
• A12. Ustaalioglu, B.B., Seker, M., Bilici, A., Canpolat, N., Yıldırım, E., Kefeli, U., Ustaalioglu, R., Yılmaz, B.E., Salepci, T., Özdemir, N., Gümüş, M. (2011). The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Med Oncol, 28, 258–264. DOI: 10.1007/s12032-010-9446-7

B. Доклады на международных научных конференциях (опубликованные материалы)

• B1. Bilici, A., Ustaalioglu, B.B.O., Orcun, A., Ercan, S., Seker, M., Kefeli, U., Yılmaz, B.E., Yıldırım, M.E., Gezen, C., Gümüş, M. (2010). Plasma M30 and M65 levels in patients with advanced gastric cancer: Is there an impact on survival? Annals of Oncology, 21 (suppl 8), viii48, 35th ESMO Congress, Milan, Italy, 8–12 October.
• B2. Ustaalioglu, B.B.O., Bilici, A., Ercan, S., Orcun, A., Seker, M., Kefeli, U., Ozkan, A., Yılmaz, B.E., Yıldırım, M.E., Gümüş, M. (2010). Serum M30 and M65 values in patients with advanced stage non-small cell lung cancer compared with healthy control group. Annals of Oncology, 21 (suppl 8), viii72, 35th ESMO Congress, Milan, Italy, 8–12 October.
• B3. Ustaalioglu, B.O., Seker, M., Bilici, A., Salepci, T., Kefeli, U., Oncel, M., Yıldırım, E., Yılmaz, B., Kement, M., Gümüş, M. (2010). The importance of liver metastasectomy in metastatic colorectal cancer patients: Single-center experiences. Annals of Oncology, 21 (suppl 6), vi68, p0141, 12th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 30 June–3 July.
• B4. Bilici, A., Ustaalioglu, B.B., Gümüş, M., Seker, M., Yılmaz, B., Sonmez, B., Yıldırım, E., Kefeli, U., Salepci, T., Kement, M. (2010). Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Proceedings, 62, abstr. 20, ASCO Gastrointestinal Cancers Symposium, Orlando, Florida, USA, 22–24 January.

D. Статьи, опубликованные в национальных рецензируемых журналах

• D1. Ustaalioglu, B.B.Ö., Bilici, A., Seker, M., Salepçi, T., Yıldırım, E., Kefeli, U., Kement, M., Gümüş, M. (2009). Inflammatory breast cancer series: Single-center experience. Acta Oncologica Turcica, 42, 93–99.
• D2. Ustaalioglu, B.B.Ö., Seker, M., Bilici, A., Erkol, B., Kefeli, U., Yıldırım, E., Sonmez, B., Gümüş, M., Salepçi, T. (2008). A rare case of nasolacrimal hemangiopericytoma. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, 19, 93–96.

E. Доклады на национальных научных конференциях (опубликованные материалы)

• E1. Bilici, A., Sürmeli Yapıcı, H., Ercan, Ş., Ustaalioglu, B.B.Ö., Seker, M., Salman, T., Yıldırım, E., Salepçi, T., Orçun, A., Gümüş, M. (2011). Relationship between rheumatologic parameters and presence of autoimmune diseases in patients with non-Hodgkin lymphoma. 19th National Cancer Congress, S17, 27, 24–28 April, Antalya.
• E2. Ustaalioglu, B.B.Ö., Seker, M., Bilici, A., Yılmaz, B.E., Yıldırım, E., Salepçi, T., Cömert, S.Ş., Gümüş, M. (2011). Outcomes in patients with large cell neuroendocrine carcinoma of the lung. 19th National Cancer Congress, P002, 100, 24–28 April, Antalya.
• E3. Yılmaz, B.E., Bilici, A., Erkol, G., Seker, M., Ustaalioglu, B.B.Ö., Kefeli, U., Yıldırım, M.E., Salepçi, N.T. (2011). Renal chromophobe carcinoma with synchronous extra-adrenal paraganglioma: A rare case report. 19th National Cancer Congress, P449, 578, 24–28 April, Antalya.
• E4. Bilici, A., Seker, M., Ustaalioglu, B.B.Ö., Kefeli, U., Yıldırım, E., Yavuzer, D., Aydın, F.M., Salepçi, T., Oncel, M., Gümüş, M. (2010). Prognostic significance of perineural invasion in patients with gastric cancer. 3rd Medical Oncology Congress, 3, S02, 24–28 March, Antalya.
• E5. Kefeli, U., Ustaalioglu, B.B.Ö., Kaya, S., Gümüş, M., Yıldırım, E., Bilici, A., Seker, M., Yılmaz, B.E., Kefeli, A.Ü., Ustaalioglu, R., Salepçi, T., Uygun, K. (2010). Adjuvant treatment analysis in resectable non-small cell lung cancer: Two-center experience. 3rd Medical Oncology Congress, 17, S30, 24–28 March, Antalya.
• E6. Ustaalioglu, B.B.Ö., Bilici, A., Seker, M., Kefeli, U., Salepçi, T., Yıldırım, E., Kement, M., Gezen, C., Gümüş, M. (2010). Prognostic significance of metastatic lymph node ratio in patients with breast cancer: Single-center study. 3rd Medical Oncology Congress, 19, S36, 24–28 March, Antalya.
• E7. Kefeli, U., Bilici, A., Ustaalioglu, B.B.Ö., Kefeli, A.Ü., Yıldırım, M.E., Seker, M., Yılmaz, B., Salepçi, T., Gümüş, M. (2010). Complete response in a patient with metastatic breast cancer treated with lapatinib and capecitabine combination: First case report. 3rd Medical Oncology Congress, 75, p101, 24–28 March, Antalya.
• E8. Seker, M., Ustaalioglu, B.B.Ö., Bilici, A., Yılmaz, B.E., Kefeli, U., Yıldırım, E., Yaşar, N., Salepçi, T., Gümüş, M. (2010). Evaluation of intestinal lymphoma cases. 2nd National Gastrointestinal Oncology Congress, 55, p38, 7–11 April, Antalya.
• E9. Ustaalioglu, B.B.Ö., Seker, M., Bilici, A., Salepçi, T., Kefeli, U., Yıldırım, E., Yılmaz, B., Oncel, M., Gümüş, M. (2010). Our data on metastasectomy in metastatic colon cancer: Single-center experience. 2nd National Gastrointestinal Oncology Congress, 23, p6, 7–11 April, Antalya.
• E10. Seker, M., Mengi, A., Bilici, A., Ustaalioglu, B.B., Yılmaz, B.E., Kefeli, U., Yıldırım, E., Yaşar, N., Özşeker, N., Yıldız, R., Salepçi, T., Gümüş, M. (2010). Retrospective evaluation of Hodgkin lymphoma cases and identification of prognostic factors. 7th National Medical Oncology Congress, p35, 22–26 September, Antalya.
• E11. Ustaalioglu, B.B.Ö., Gümüş, M., Bilici, A., Seker, M., Ustaalioglu, R., Kefeli, U., Yıldırım, E., Erkol, B., Salepçi, T., Canpolat, N., Doğusoy, I. (2009). Is there a cut-off value for PET standardized uptake in predicting survival in locally advanced non-small cell lung cancer? 6th National Medical Oncology Congress, 16, Abstract 08, 24–28 September, Antalya.
• E12. Bilici, A., Ustaalioglu, B.B.Ö., Gümüş, M., Seker, M., Yılmaz, B., Sonmez, B., Yıldırım, E., Kefeli, U., Salepçi, T., Kement, M., Mayadağlı, A. (2009). Is metastatic lymph node ratio superior to the number of metastatic lymph nodes in predicting prognosis of gastric cancer patients? 6th National Medical Oncology Congress, 31, Abstract 19, 24–28 September, Antalya.
• E13. Kefeli, U., Kaya, S., Gümüş, M., Ustaalioglu, B.B.Ö., Yıldırım, M.E., Bilici, A., Yılmaz, B.E., Seker, M., Sonmez, B., Salepçi, T., Mayadağlı, A., Fidan, A., Uygun, K. (2009). Prognostic factors and survival outcomes in elderly patients with non-small cell lung cancer. 6th National Medical Oncology Congress, 43, Abstract 31, 24–28 September, Antalya.